AU2021457908B9 - Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation - Google Patents

Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Info

Publication number
AU2021457908B9
AU2021457908B9 AU2021457908A AU2021457908A AU2021457908B9 AU 2021457908 B9 AU2021457908 B9 AU 2021457908B9 AU 2021457908 A AU2021457908 A AU 2021457908A AU 2021457908 A AU2021457908 A AU 2021457908A AU 2021457908 B9 AU2021457908 B9 AU 2021457908B9
Authority
AU
Australia
Prior art keywords
tablets
constipation
magnesium oxide
defecation
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2021457908A
Other languages
English (en)
Other versions
AU2021457908B2 (en
AU2021457908A1 (en
Inventor
Hazuki ONISHI
Daisuke SHIBUTANI
Yuya YOSHIMURA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SETOLAS Holdings Inc
Original Assignee
SETOLAS Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SETOLAS Holdings Inc filed Critical SETOLAS Holdings Inc
Publication of AU2021457908A1 publication Critical patent/AU2021457908A1/en
Application granted granted Critical
Publication of AU2021457908B2 publication Critical patent/AU2021457908B2/en
Priority to AU2025275199A priority Critical patent/AU2025275199A1/en
Publication of AU2021457908B9 publication Critical patent/AU2021457908B9/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2021457908A 2021-07-30 2021-12-24 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation Active AU2021457908B9 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025275199A AU2025275199A1 (en) 2021-07-30 2025-12-04 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021126021 2021-07-30
JP2021-126021 2021-07-30
PCT/JP2021/048377 WO2023007766A1 (ja) 2021-07-30 2021-12-24 酸化マグネシウムを含有する小児慢性機能性便秘症治療用医薬組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025275199A Division AU2025275199A1 (en) 2021-07-30 2025-12-04 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Publications (3)

Publication Number Publication Date
AU2021457908A1 AU2021457908A1 (en) 2024-02-15
AU2021457908B2 AU2021457908B2 (en) 2025-09-04
AU2021457908B9 true AU2021457908B9 (en) 2026-02-05

Family

ID=85086576

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2021457908A Active AU2021457908B9 (en) 2021-07-30 2021-12-24 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
AU2025275199A Pending AU2025275199A1 (en) 2021-07-30 2025-12-04 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025275199A Pending AU2025275199A1 (en) 2021-07-30 2025-12-04 Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation

Country Status (6)

Country Link
US (1) US20250000898A1 (https=)
EP (1) EP4378467A4 (https=)
JP (3) JP7233516B2 (https=)
CN (1) CN117677390A (https=)
AU (2) AU2021457908B9 (https=)
WO (1) WO2023007766A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10120554A (ja) * 1996-10-15 1998-05-12 Fuji Chem Ind Co Ltd 無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
WO2010098417A1 (ja) * 2009-02-25 2010-09-02 協和化学工業株式会社 酸化マグネシウム細粒
WO2020101016A1 (ja) * 2018-11-16 2020-05-22 協和化学工業株式会社 緩下用錠剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0415485A (ja) 1990-05-09 1992-01-20 Murata Mfg Co Ltd 連続式焼成炉

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10120554A (ja) * 1996-10-15 1998-05-12 Fuji Chem Ind Co Ltd 無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
WO2010098417A1 (ja) * 2009-02-25 2010-09-02 協和化学工業株式会社 酸化マグネシウム細粒
WO2020101016A1 (ja) * 2018-11-16 2020-05-22 協和化学工業株式会社 緩下用錠剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KUBOTA MEGUMI, ET AL. "Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial", NUTRIENTS, 2020, vol. 12, no. 1, article 225, DOI:10.3390/nu12010225 *

Also Published As

Publication number Publication date
JP7669493B2 (ja) 2025-04-28
JP2025085856A (ja) 2025-06-05
US20250000898A1 (en) 2025-01-02
JPWO2023007766A1 (https=) 2023-02-02
CN117677390A (zh) 2024-03-08
EP4378467A1 (en) 2024-06-05
EP4378467A4 (en) 2025-07-30
AU2021457908B2 (en) 2025-09-04
AU2021457908A1 (en) 2024-02-15
WO2023007766A1 (ja) 2023-02-02
JP2023020835A (ja) 2023-02-09
JP7233516B2 (ja) 2023-03-06
AU2025275199A1 (en) 2026-01-15

Similar Documents

Publication Publication Date Title
AU2009202429B2 (en) Pharmaceutical formulation comprising lanthanum compounds
JP7360503B2 (ja) 緩下用錠剤
TW201690B (https=)
US3885027A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
AU2021457908B9 (en) Magnesium oxide-containing pharmaceutical composition for treating pediatric chronic functional constipation
US20160279166A1 (en) Treating agent and treating method for the examination or operation of the large intestine
DE2519528A1 (de) Arzneimittel fuer die orale verabreichung
US9744135B2 (en) Fast disintegrating compositions and tablets thereof
AT12928U1 (de) Formulierungen
Sadovsky Surgery for treatment of intussusception in an adult.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
SREP Specification republished